Search products

Search by product name, CAT, CAS, molecular formula or chemical name.

Trusted Partner for Reference Standards and Beyond
Products About us Facility Quality system OUR DIVISIONS SimSon Chemtech Speciality & fine chemicals SimSon Chemie Research chemicals supply SimSon Lifescience Services CRO, CDMO & analytical testing Contact us Careers
Home/ Products/ Bosutinib/ Bosutinib N-Oxide Impurity 3

Bosutinib N-Oxide Impurity 3

Structure of Bosutinib N-Oxide Impurity 3
CAT. No. B1020039
CAS No. NA
Mol. Formula C26H29Cl2N5O4
Mol. Weight 546.45 g/mol
Chemical Name 4-(3-((3-cyano-4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinolin-7-yl)oxy)propyl)-1-methylpiperazine 4-oxide
Synonyms NA
Smiles Code CN1CC[N+](CCCOC2=C(OC)C=C3C(NC4=CC(OC)=C(Cl)C=C4Cl)=C(C#N)C=NC3=C2)([O-])CC1
Stock Status Custom Synthesis

Technical Description

Bosutinib N-Oxide Impurity 3 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.

Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.

Product Applications & Regulatory Search Terms:

Bosutinib N-Oxide Impurity 3 for method validation Bosutinib N-Oxide Impurity 3 reference standard Bosutinib N-Oxide Impurity 3 for ANDA filing Bosutinib N-Oxide Impurity 3 for forced degradation studies Bosutinib N-Oxide Impurity 3 identification standard Bosutinib N-Oxide Impurity 3 for DMF filing Bosutinib N-Oxide Impurity 3 HPLC standard Bosutinib N-Oxide Impurity 3 supplier Bosutinib N-Oxide Impurity 3 manufacturer Bosutinib N-Oxide Impurity 3 distributor

Search COA by Batch No.

Find the Certificate of Analysis for a specific product batch.

Request a quote

Tell us what you need. Our technical desk normally replies within one working day.

Request a quote for Bosutinib N-Oxide Impurity 3

Share the required quantity, destination, intended analytical use and supporting documents you need. The technical desk will confirm the applicable product details, availability and quotation.

FOR INTERNATIONAL +91 87673 60663 info@simsonpharma.com
Technical desk · Mon–Sat, 09:30–18:30 IST
Bosutinib N-Oxide Impurity 3 · B1020039
PRODUCT NAME
This form is protected by server-side validation, rate limiting and spam detection. By sending it, you agree to our privacy policy.
We reply within one working day.
DISCLAIMER This page supports product identification and initial technical evaluation. Specifications, assigned values, pack options, availability and documentation may vary by product or batch; verify the applicable details in the current quotation, label and supplied records before use. The purchaser or importer is responsible for determining method suitability and meeting local regulatory, transport and import requirements. For research, analytical and quality-control use only. Not for human or veterinary consumption, and not for use as a medicine.
Bosutinib N-Oxide Impurity 3 CAT. No. B1020039 · CAS NA · 546.45 g/mol
✕
Structure of Bosutinib N-Oxide Impurity 3

Sample structure

Catalogue no.: — CAS no.: — Formula: — Mol. weight: —

Illustrative sample structure
SimSon — Science Standards Solutions
D-U-N-S Registered — Dun & Bradstreet D-U-N-S® REGISTERED Verified by Dun & Bradstreet
OFFICES & LABORATORIES
REGISTERED OFFICE · MUMBAI B-307, Sarita Building, Prabhat Industrial Estate, Near Dahisar Toll Naka, Dahisar (East), Mumbai- 400068, Maharashtra, India
CORPORATE OFFICE · MUMBAI Unit 1001-1006, The Platina, Tanvi Complex, S. V. Road, Dahisar East, Mumbai 400068, India
LABORATORY · HYDERABAD Shed 6A, TYPE III, TSIIC, Prashanthi Nagar, Kukatpally, Hyderabad 500072, India
REGIONAL OFFICE · AHMEDABAD Survey Number 375 Paiki 1, Plot Number 11, Shivam 5, Near Sumip Composite, Panchratna Estate, Village Changodar, Taluka Sanand, District Ahmedabad, Gujarat-382213
TALK TO THE RIGHT DESK
© 2026 SimSon Pharma Limited · All rights reserved